L. Tartar Trust to BJP, and the University of Puget definitely Sound Richard Bangs Collier scholarship to SMC. Declaration of Interests None declared. Supplementary Material Supplementary Data: Click here to view. Acknowledgments Special thanks to Jacob Raber, Ph.D., as well as Reid Olsen, Julie Mitchell, M.S., and Ruth Rowland for their technical support; Jean O��Malley, M.P.H., for statistical advice; Joel T. Nigg, Ph.D., for reading an earlier version of this manuscript; and the mothers that took part in this study.
The Family Smoking Prevention and Tobacco Control Act of 2009 (the ��Act��) represents an important landmark for tobacco control in the United States. The Act granted the U.S. Food and Drug Administration (FDA) authority to regulate tobacco products, including packaging and labeling regulations (Deyton, Sharfstein, & Hamburg, 2010).
Internationally, packaging and labeling regulations have emerged as an important component of tobacco control policy, both as a vehicle for governments to warn about the risks of tobacco use and to restrict misleading descriptors and design. Article 11 of the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC)��the world��s first public health treaty��has served as an impetus for the rapid uptake of packaging and labeling regulations among many of the 170 countries that have ratified the Framework (WHO, 2003). Article 11 includes recommendations for large pictorial health warnings and encourages more effective forms of disclosure for product constituents and emissions.
Article 11 also recognizes the importance of the package as a promotional vehicle for tobacco companies and requires the removal of potentially misleading packaging information, including the terms ��light�� and ��mild.�� Article 11 advises that Parties to consider broader restrictions on other descriptors and promotional elements of pack design (WHO, 2008). Packaging regulations have changed very little in the United States since 1984, when packages began displaying one of four mandatory text warnings printed on the side of packages (see Figure 1). However, the Act gives the FDA authority to regulate three primary areas of packaging and labeling: health warnings, the disclosure of product constituents or chemical Carfilzomib ��yields,�� and prohibitions on potentially misleading packaging information with respect to reduced health risk. The current paper will examine regulatory provisions in each of these areas, review evidence on best practices, and identify research priorities to help guide regulatory practice. Figure 1. U.S. health warnings implemented in 1984. The United States is a critical market for global tobacco control.